Prelamin A is involved in early steps of muscle differentiation.

[1]  R. Foisner,et al.  Drugs affecting prelamin A processing: effects on heterochromatin organization. , 2008, Experimental cell research.

[2]  R. Foisner,et al.  Pre‐Lamin A processing is linked to heterochromatin organization , 2007, Journal of cellular biochemistry.

[3]  C. Bodemer,et al.  Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence , 2007, Cell Death and Differentiation.

[4]  R. Foisner,et al.  Lamins and lamin-associated proteins in aging and disease. , 2007, Current opinion in cell biology.

[5]  M. Schuelke,et al.  Muscle and nerve pathology in Dunnigan familial partial lipodystrophy , 2007, Neurology.

[6]  R. Foisner,et al.  Nucleoplasmic LAP2α–lamin A complexes are required to maintain a proliferative state in human fibroblasts , 2007, The Journal of cell biology.

[7]  R. Hennekam.  Hutchinson–Gilford progeria syndrome: Review of the phenotype , 2006, American journal of medical genetics. Part A.

[8]  A. Rusiñol,et al.  Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors , 2006, Journal of Cell Science.

[9]  J. Broers,et al.  Nuclear lamins: laminopathies and their role in premature ageing. , 2006, Physiological reviews.

[10]  F. Collins,et al.  Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Foisner,et al.  Lamina-associated polypeptide 2α regulates cell cycle progression and differentiation via the retinoblastoma–E2F pathway , 2006, The Journal of cell biology.

[12]  E. Hoffman,et al.  Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. , 2006, Human molecular genetics.

[13]  Richard L. Frock,et al.  Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. , 2006, Genes & development.

[14]  L. Mestroni,et al.  Thymopoietin (lamina‐associated polypeptide 2) gene mutation associated with dilated cardiomyopathy , 2005, Human mutation.

[15]  G. Novelli,et al.  Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment , 2005, Cellular and Molecular Life Sciences.

[16]  G. Scarano,et al.  Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. , 2005, Physiological genomics.

[17]  G. Novelli,et al.  Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. , 2005, Human molecular genetics.

[18]  M. Lisanti,et al.  Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. , 2005, American journal of physiology. Cell physiology.

[19]  A. K. Agarwal,et al.  Compound heterozygous ZMPSTE24 mutations reduce prelamin A processing and result in a severe progeroid phenotype , 2005, Journal of Medical Genetics.

[20]  T. Misteli,et al.  Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome , 2005, Nature Medicine.

[21]  C. Capanni,et al.  Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery–Dreifuss muscular dystrophy , 2005, Journal of Medical Genetics.

[22]  H. Mabuchi,et al.  Gene mutations in adult Japanese patients with dilated cardiomyopathy. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[23]  E. Markiewicz,et al.  Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro , 2005, Journal of Cell Science.

[24]  C. Bönnemann,et al.  p.S143F mutation in lamin A/C: A new phenotype combining myopathy and progeria , 2005, Annals of neurology.

[25]  W. H. Schaefer,et al.  Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone. , 2004, Toxicology and applied pharmacology.

[26]  B. Buendia,et al.  Expression of a Mutant Lamin A That Causes Emery-Dreifuss Muscular Dystrophy Inhibits In Vitro Differentiation of C2C12 Myoblasts , 2004, Molecular and Cellular Biology.

[27]  Aaron J. Peoples,et al.  Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C. , 2003, Molecular biology of the cell.

[28]  N. Maraldi,et al.  Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts. , 2003, Biochemical and biophysical research communications.

[29]  N. Rangaraj,et al.  Distinct changes in intranuclear lamin A/C organization during myoblast differentiation. , 2001, Journal of cell science.

[30]  N. Chaly,et al.  Remodelling of the nuclear periphery during muscle cell differentiation in vitro , 1996, Journal of cellular biochemistry.

[31]  J. Lin,et al.  Expression of wild-type and nuclear localization-deficient human lamin A in chick myogenic cells. , 1992, Journal of cell science.

[32]  J. Laliberté,et al.  Detection in BHK cells of a precursor form for lamin A. , 1985, Experimental cell research.

[33]  N. Maraldi,et al.  Involvement of prelamin A in laminopathies. , 2007, Critical reviews in eukaryotic gene expression.

[34]  N. Maraldi,et al.  Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies. , 2006, European journal of histochemistry : EJH.

[35]  Katherine L. Wilson,et al.  The nuclear lamina comes of age , 2005, Nature Reviews Molecular Cell Biology.